Madeleine Fajilan
Psychiatric/Mental Health · Mission Viejo, CANPI 1548810591
Payments from drug & device makers
Across 252 payments — averaging $29.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$940
- Johnson & Johnson$920
- Otsuka America Pharmaceutical, Inc.$797
- Vanda Pharmaceuticals Inc.$742
- AbbVie$543
- Alkermes, Inc.$511
- plus $3K from 16 others
What the payments were for
- Food & beverage$7,436100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 32 | $940 |
| Johnson & Johnson | 20 | $920 |
| Otsuka America Pharmaceutical, Inc. | 28 | $797 |
| Vanda Pharmaceuticals Inc. | 22 | $742 |
| AbbVie | 20 | $543 |
| Alkermes, Inc. | 22 | $511 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 19 | $503 |
| Teva Pharmaceuticals USA, Inc. | 15 | $395 |
| E.r. Squibb & Sons, L.L.C. | 13 | $353 |
| Supernus Pharmaceuticals, Inc. | 10 | $332 |
| Axsome Therapeutics, Inc. | 12 | $304 |
| Biogen | 7 | $290 |
| Luye Pharma (USA) Ltd. | 3 | $171 |
| Indivior Inc. | 2 | $138 |
| Lundbeck LLC | 8 | $137 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $115 |
| Noven Therapeutics, LLC | 5 | $93 |
| Collegium Pharmaceutical, Inc. | 3 | $65 |
| Corium, LLC | 1 | $27 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $23 |
| Braeburn Inc. | 1 | $20 |
| OWP Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$482
- SPRAVATO$251
- VRAYLAR$245
- INVEGA SUSTENNA$150
- ABILIFY MAINTENA$146
- ABILIFY ASIMTUFII$146
- UZEDY$140
- CAPLYTA$129
- ERZOFRI EXTENDED-RELEASE$128
- QELBREE$124
- Zurzuvae$121
- SUBLOCADE$114
- INVEGA TRINZA$109
- REXULTI$102
How this compares
$7,436 in reported general payments places this provider in the 95th percentile of 2,433 psychiatric/mental health providers in California.
Other psychiatric/mental health in Mission Viejo
- Sarah KantelisMission Viejo$25K
- Krista FendrickMission Viejo$14K
- Carey MartinMillbrae$745K
- Liberty MaciasRedlands$288K
- Joshua BurgettSacramento$239K
- Jovita Ezirim-SalamialofojeLos Angeles$162K
- Angie-Kolleen TanThousand Oaks$159K
- Thy LamVista$121K
- David OhIrvine$72K
- Samantha PerkinsAnaheim$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.